NASDAQ: CBATCbak Energy Technology Inc Stock
$0.87-0.01 (-1.14%)
Updated May 16, 2025
CBAT Price
$0.87
Fair Value Price
N/A
Market Cap
$78.43M
52 Week Low
$0.57
52 Week High
$2.08
P/E
6.71x
P/B
0.64x
P/S
0.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$176.61M
Earnings
$11.79M
Gross Margin
23.7%
Operating Margin
6.83%
Profit Margin
6.7%
Debt to Equity
1.5
Operating Cash Flow
$40M
Beta
1.51
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CBAT Overview
CBAK Energy Technology, Inc., together with its subsidiaries, develops, manufactures, and sells lithium batteries in Mainland China, the United States, Korea, Europe, and internationally. Its products are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles that include electric bicycles, electric motors, and sight-seeing cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. The company was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017. CBAK Energy Technology, Inc. was incorporated in 1999 and is based in Dalian, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CBAT's potential to beat the market
- CBAT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Electrical Equipment & Part
Industry Rating
C
CBAT
RankedUnranked of 37
RankedUnranked of 37
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $99.91 | A | |
| $36.50 | A | |
| $138.21 | A |
Be the first to know about important CBAT news, forecast changes, insider trades & much more!
CBAT News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CBAT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CBAT is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CBAT is good value based on its earnings relative to its share price (6.71x), compared to the US market average (25.95x)
P/E vs Market Valuation
CBAT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CBAT due diligence checks available for Premium users.
Valuation
CBAT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.71x
Industry
61.11x
Market
25.95x
CBAT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CBAT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CBAT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.64x
Industry
4.76x
CBAT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CBAT's financial health
Profit margin
Revenue
$25.4M
Net Income
-$4.5M
Profit Margin
-17.8%
CBAT's Earnings (EBIT) of $12.07M... subscribe to Premium to read more.
Interest Coverage Financials
CBAT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$302.2M
Liabilities
$182.2M
Debt to equity
1.5
CBAT's short-term liabilities ($171.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBAT's short-term assets ($141.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBAT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CBAT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.6M
Investing
-$3.3M
Financing
$9.8M
CBAT's operating cash flow ($39.70M)... subscribe to Premium to read more.
Debt Coverage Financials
CBAT vs Electrical Equipment & Part Stocks
Cbak Energy Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.